Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban have?
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban has 173 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban published?
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban has 2015 year in the ScholarIQ index.
What is the open-access status of Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban?
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban has closed oa status in the ScholarIQ index.
What is the DOI of Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban?
The DOI for Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban is on the source record.
What is the PMID of Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban?
The PMID for Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban is on the source record.
What is the OpenAlex record for Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban?
The OpenAlex for Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban is on the source record.